Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-027535)

Filing Details

Accession Number:: 0001127602-13-027535
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-19 14:14:55
Reporting Period:: 2013-09-18

Filing Date:: 2013-09-19
Accepted Time:: 2013-09-19 14:14:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875045	Biogen Idec Inc.	BIIB	Biological Products, (No Disgnostic Substances) (2836)	330112644

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1409601	J Paul Clancy	Biogen Idec Inc. 133 Boston Post Road Weston MA 02493	Executive Vp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-18	26,785	$49.65	33,872	No	4	M	Direct
Common Stock	Disposition	2013-09-18	26,785	$245.00	7,087	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-09-18	26,785	$0.00	26,785	$49.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-02-24	No	4	M	Direct

Footnotes

Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.